9 research outputs found

    The Marinoan cap carbonate of Svalbard: Syngenetic marine dolomite with <sup>17</sup>O-anomalous carbonateā€associated sulphate

    Get PDF
    Two cap carbonates overlying Cryogenian panglacial deposits are found in North- East Svalbard of which the younger (635 Ma) forms the base of the Ediacaran Period. It is represented by a transgressive succession in which laminated do-lostone, typically around 20 m thick (Member D1), is succeeded transitionally by a similar thickness of impure carbonates (Member D2). In Spitsbergen, there is evidence of microbially influenced sediment stabilisation and carbonate precipitation in the lower part of D1, whilst the upper part of D1 and D2 show centimetre- decimetre- scale graded units with undulatory lamination interpreted as evidence of storm activity. Carbonate originated as possible freshwater whitings, as well as microbial precipitates. Exhumed and eroded hardgrounds display replacive 10ā€“ 30 Ī¼m dolomite crystals with cathodoluminescence characteris-tics consistent with early diagenetic manganese and iron reduction. Regionally, carbon isotope values consistently decrease by around 2ā€° from around āˆ’3ā€° over 30 m of section which is both a temporal and a bathymetric signal, but not a global one. An exponential decline in carbonate production predicted by box models is fitted by a semi- quantitative sedimentation model. A mass- anomalous 17O depletion in carbonate- associated sulphate in dolomite, inherited from pre-cursor calcite, decreases from āˆ’0.6 to āˆ’0.3ā€° in the basal 15 m of section and then approaches background values. The post- glacial anomalous 17O depletion in carbonate- associated sulphate and barite elsewhere has been interpreted in terms of ultra- high pCO2 at the onset of deglaciation. Such anomalies, with larger amplitude, have been reported in Svalbard from underlying lacustrine and tufa-ceous limestones representing a hyperarid glacial environment. The anomalous sulphate could be produced contemporarily, or the internally drained landscape may have continued to release 17O-anomalous sulphate as it was transgressed during cap carbonate deposition. The late Cryogenian to earliest Ediacaran record in Svalbard provides the most complete record of the basal 17O - depletion event in the world

    Developing and investigating a nanovibration intervention for the prevention/reversal of bone loss following spinal cord injury

    No full text
    Osteoporosis disrupts the fine-tuned balance between bone formation and resorption, leading to reductions in bone quantity and quality and ultimately increasing fracture risk. Prevention and treatment of osteoporotic fractures is essential for reductions in mortality, morbidity and the economic burden, particularly considering the ageing global population. Extreme bone loss that mimics time-accelerated osteoporosis develops in the paralysed limbs following complete spinal cord injury (SCI). In vitro nanoscale vibration (1 kHz, 30- or 90 nm amplitude) has been shown to drive differentiation of mesenchymal stem cells towards osteoblast-like phenotypes, enhancing osteogenesis and inhibiting osteoclastogenesis simultaneously. Here, we develop and characterise a wearable device designed to deliver and monitor continuous nano-amplitude vibration to the hindlimb long bones of rats with complete SCI. We investigate whether a clinically feasible dose of nanovibration (two 2-hours/day, 5-days/week for 6 weeks) is effective at reversing the established SCI-induced osteoporosis. Laser interferometry and finite element analysis confirmed transmission of nanovibration into the bone, and micro-computed tomography and serum bone formation and resorption markers assessed effectiveness. The intervention did not reverse SCI-induced osteoporosis. However, serum analysis indicated an elevated concentration of the bone formation marker procollagen type 1 N-terminal propeptide (P1NP) in rats receiving 40 nm amplitude nanovibration, suggesting increased synthesis of type 1 collagen, the major organic component of bone. Therefore, enhanced doses of nanovibrational stimulus may yet prove beneficial in attenuating/reversing osteoporosis, particularly in less severe forms of osteoporosis

    Localization and expression of selenoprotein S in the testis of Psammomys obesus

    Full text link
    Selenium is an essential trace element and selenoprotein S is a member of the selenoprotein family that has the non-standard amino acid selenocysteine incorporated into the polypeptide. Dietary selenium has been shown to play an important protective role in a number of diseases including cancer, immune function and the male reproductive system. In this study, we have observed high levels of selenoprotein S gene expression in the testis from Psammomys obesus. Real-time PCR and immunofluorescence demonstrate that selenoprotein S expression is low in testes from 4-week-old animals but increases significantly by 8 weeks of age and remains high until 17 weeks of age. Selenoprotein S protein is detected in primary spermatocytes, Leydig and Sertoli cells of 8, 12 and 17-week-old animals. These results suggest that selenoprotein S may play a role in spermatogenesis.<br /

    A gene expression signature for insulin resistance

    Full text link
    Insulin resistance is a heterogeneous disorder caused by a range of genetic and environmental factors, and we hypothesize that its aetiology varies considerably between individuals. This heterogeneity provides significant challenges to the development of effective therapeutic regimes for long-term management of type 2 diabetes. We describe a novel strategy, using large-scale gene expression profiling, to develop a Gene Expression Signature (GES) that reflects the overall state of insulin resistance in cells and patients. The GES was developed from 3T3-L1 adipocytes that were made &lsquo;insulin resistant&rsquo; by treatment with tumour necrosis factor-alpha (TNF&alpha;) and then reversed with aspirin and troglitazone (&lsquo;re-sensitized&rsquo;). The GES consisted of five genes whose expression levels best discriminated between the insulin resistant and insulin re-sensitized states. We then used this GES to screen a compound library for agents that affected the GES genes in 3T3- L1 adipocytes in a way that most closely resembled the changes seen when insulin resistance was successfully reversed using aspirin and troglitazone. This screen identified both known and new insulin sensitizing compounds including non-steroidal anti inflammatory agents, &beta;-adrenergic antagonists, beta-lactams and sodium channel blockers. We tested the biological relevance of this GES in participants in the San Antonio Family Heart Study (n = 1,240) and showed that patients with the lowest GES scores were more insulin resistant (according to HOMA_IR and fasting plasma insulin levels, P &lt; 0.001). These findings show that GES technology can be used for both the discovery of insulin sensitizing compounds and the characterization of patients into subtypes of insulin resistance according to GES scores, opening the possibility of developing a personalized medicine approach to type 2 diabetes.<br /

    Bioactivation of Xenobiotics in Lung: Role of CYPs and FMOs

    No full text
    corecore